Foreword: Preventing COVID-19 Among the Immunocompromised Population.
Journal Information
Full Title: J Infect Dis
Abbreviation: J Infect Dis
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Communicable Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Potential conflicts of interest. M. W. has received speaker’s fees from AstraZeneca. The author has submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed."
"Notes: Acknowledgments. Medical writing and editorial assistance were provided by Emily Stackpole, PhD, and Louansha Nandlal, PhD, of MEDiSTRAVA, in accordance with Good Publication Practice (GPP 2022) guidelines, funded by Moderna, Inc., and under the direction of the author.: Supplement sponsorship. This article appears as part of the supplement “COVID-19 Vaccination in the Immunocompromised Population,” sponsored by Moderna, Inc."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025